Hemostasis Today

February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Maria Cherska: Insights from EAS 2025 on Detection and Long-Term Management of FH
Feb 20, 2026, 15:08

Maria Cherska: Insights from EAS 2025 on Detection and Long-Term Management of FH

Maria Cherska, The head of cardiology department at The State Institution «V.P. Komisarenko Institute of Endocrinology and Metabolism», shared a post on LinkedIn:

“Familial Hypercholesterolemia (FH): Rethinking Detection and Long-Term Management — Insights from EAS 2025

Familial hypercholesterolemia remains substantially underdiagnosed worldwide, despite being a major driver of premature atherosclerotic cardiovascular disease. The gap between guideline recommendations and real-world implementation is still significant.

In this expert interview from EAS 2025, Prof. Gerald Watts discusses the evolving clinical strategy for FH management — from early identification and cascade screening to long-term LDL-C control and residual risk reduction.

Key clinical takeaways:

  • Systematic early detection is critical
  • Cascade screening should be integrated into routine practice
  • Aggressive and sustained LDL-C lowering is essential
  • Residual cardiovascular risk persists even after LDL-C reduction

FH is not a rare condition — it is a common, lifelong, high-risk state that requires proactive and structured management.

Read the Full Interview.

For cardiologists, lipidologists, endocrinologists, internists, and preventive cardiology specialists focused on high-risk patient care and long-term ASCVD prevention.

How do you currently implement cascade screening and long-term LDL-C control in FH patients?”

Stay updated with Hemostasis Today.